Kidney outcome after mild to moderate COVID-19
Nephrology Dialysis Transplantation · 2023
DOI: 10.1093/ndt/gfad008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Christian Schmidt-Lauber und 13 weiteren Autor:innen. Beteiligte Einrichtung: III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: COVID-19, Pyuria. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: City of Hamburg, Germany, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a remarkable kidney tropism. While kidney effects are common in severe coronavirus disease 2019 (COVID-19), data on non-severe courses are limited. Here we provide a multilevel analysis of kidney outcomes after non-severe COVID-19 to test for eventual kidney sequela.
Methods
This cross-sectional study investigates individuals after COVID-19 and matched controls recruited from the Hamburg City Health Study (HCHS) and its COVID-19 program. The HCHS is a prospective population-based cohort study within the city of Hamburg, Germany. During the COVID-19 pandemic the study additionally recruited subjects after polymerase chain reaction–confirmed SARS-CoV-2 infections. Matching was performed by age, sex and education. Main outcomes were estimated glomerular filtration rate (eGFR), albuminuria, Dickkopf3, haematuria and pyuria.
Results
A total of 443 subjects in a median of 9 months after non-severe COVID-19 were compared with 1328 non-COVID-19 subjects. The mean eGFR was mildly lower in post-COVID-19 than non-COVID-19 subjects, even after adjusting for known risk factors {β = −1.84 [95% confidence interval (CI) −3.16 to −0.52]}. However, chronic kidney disease [odds ratio (OR) 0.90 (95% CI 0.48–1.66)] or severely increased albuminuria [OR 0.76 (95% CI 0.49–1.09)] equally occurred in post-COVID-19 and non-COVID-19 subjects. Haematuria, pyuria and proteinuria were also similar between the two cohorts, suggesting no ongoing kidney injury after non-severe COVID-19. Further, Dickkopf3 was not increased in the post-COVID-19 cohort, indicating no systematic risk for ongoing GFR decline [β = −72.19 (95% CI −130.0 to −14.4)].
Conclusion
While mean eGFR was slightly lower in subjects after non-severe COVID-19, there was no evidence for ongoing or progressive kidney sequela.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Internal Medicine IV, Nephrology and Hypertension, Saarland University, Homburg/Saar, Germany.
- Department of Cardiology, University Heart and Vascular Center, Hamburg, Germany.
- Institute of Medical Systems Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
ORCID-Profile: Christian Schmidt-Lauber, Elina L Petersen, Raphael Twerenbold, Tobias B Huber
Förderung
- City of Hamburg, Germany
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Else Kroner-Fresenius Foundation
Zitieren
APA
Schmidt-Lauber, C., Hänzelmann, S., Schunk, S., Petersen, E. L., Alabdo, A., Lindenmeyer, M., Hausmann, F., Kuta, P., Renné, T., Twerenbold, R., Zeller, T., Blankenberg, S., Fliser, D., & Huber, T. B. (2023). Kidney outcome after mild to moderate COVID-19. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad008
Vancouver
Schmidt-Lauber C, Hänzelmann S, Schunk S, Petersen EL, Alabdo A, Lindenmeyer M, et al. Kidney outcome after mild to moderate COVID-19. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfad008
BibTeX
@article{SchmidtLauber2023,
author = {Schmidt-Lauber, Christian and Hänzelmann, Sonja and Schunk, Stefan and Petersen, Elina L and Alabdo, Ammar and Lindenmeyer, Maja and Hausmann, Fabian and Kuta, Piotr and Renné, Thomas and Twerenbold, Raphael and Zeller, Tanja and Blankenberg, Stefan and Fliser, Danilo and Huber, Tobias B},
title = {Kidney outcome after mild to moderate COVID-19},
journal = {Nephrology Dialysis Transplantation},
year = {2023},
doi = {10.1093/ndt/gfad008}
}
EUVIMED